2,N6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 11, 2007, Pages 3796-3802

  Rodenko, Boris ^a   Van Der Burg, Alida M ^a   Wanner, Martin J ^a   Kaiser, Marcel ^b   Brun, Reto ^b   Gould, Matthew ^c   De Koning, Harry P ^c   Koomen, Gerrit Jan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOPENTYLAMINO N6 CYCLOPENTYLADENINE; 2 CYCLOPENTYLAMINO N6 CYCLOPENTYLADENOSINE; 2 HISTAMINO N6 2,2 DIPHENYLETHYLADENOSINE DERIVATIVE; 2 METHOXY N6 CYCLOPENTYLADENOSINE DERIVATIVE; ADENINE DERIVATIVE; ADENOSINE DERIVATIVE; ANTIMALARIAL AGENT; ANTITRYPANOSOMAL AGENT; CHLOROQUINE; MEFLOQUINE; MELARSOPROL; N6 (3 IODOBENZYL)ADENOSINE DERIVATIVE; N6 NAPHTHYLMETHYLADENOSINE DERIVATIVE; NAPHTHALENE; PENTAMIDINE; PHENETHYLAMINE DERIVATIVE; PURINE; UNCLASSIFIED DRUG; ADENOSINE; DRUG DERIVATIVE;

AMASTIGOTE; ANTIMALARIAL ACTIVITY; ARTICLE; CALCULATION; DIFFUSION; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; HYDROPHOBICITY; IN VITRO STUDY; LEISHMANIA DONOVANI; MOLECULAR DYNAMICS; NONHUMAN; OCTANOL WATER COEFFICIENT; PLASMODIUM; PRIORITY JOURNAL; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI; TRYPANOSOMA RHODESIENSE; TRYPOMASTIGOTE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; PLASMODIUM FALCIPARUM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ADENOSINE; ANIMALS; ANTIMALARIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MOLECULAR STRUCTURE; PLASMODIUM FALCIPARUM; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA CRUZI;

EID: 35848957437     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00425-07     Document Type: Article

References (37)

1. Al Salabi, M. I., and H. P. De Koning. 2005. Purine nucleobase transport in amastigotes of Leishmania mexicana: involvement in allopurinol uptake. Antimicrob. Agents Chemother. 49:3682-3689.
2. Al Salabi, M. I., L. J. Wallace, A. Luscher, P. Maser, D. Candlish, B. Rodenko, M. K. Gould, I. Jabeen, S. N. Ajith, and H. P. De Koning. 2007. Molecular interactions underlying the unusually high adenosine affinity of a novel Trypanosoma brucei nucleoside transporter. Mol. Pharmacol. 71:921-929.
3. Barrett, M. P., R. J. Burchmore, A. Stich, J. O. Lazzari, A. C. Frasch, J. J. Cazzulo, and S. Krishna. 2003. The trypanosomiases. Lancet 362:1469-1480.
4. Berens, R. L., E. C. Krug, and J. J. Marr. 1995. Purine and pyrimidine metabolism, p. 89-117. In J. J. Marr and M. Muller (ed.), Biochemistry and molecular biology of parasites. Academic Press, Inc., New York, NY.
5. 6-substituted adenosine. J. Med. Chem. 43: 4135-4150.
6. Bressi, J. C., C. L. Verlinde, A. M. Aronov, M. L. Shaw, S. S. Shin, L. N. Nguyen, S. Suresh, F. S. Buckner, W. C. Van Voorhis, I. D. Kuntz, W. G. Hol, and M. H. Gelb. 2001. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. J. Med. Chem. 44:2080-2093.
7. Brun, R., R. Schumacher, C. Schmid, C. Kunz, and C. Burri. 2001. The phenomenon of treatment failures in human African trypanosomiasis. Trop. Med. Int. Health 6:906-914.
8. Croft, S. L. 2001. Monitoring drug resistance in leishmaniasis. Trop. Med. Int. Health 6:899-905.
9. De Koning, H. P. 2001. Transporters in African trypanosomes: role in drug action and resistance. Int. J. Parasitol. 31:512-522.
10. De Koning, H. P., D. J. Bridges, and R. J. Burchmore. 2005. Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy. FEMS Microbiol. Rev. 29:987-1020.
11. De Koning, H. P., and S. M. Jarvis. 1999. Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: substrate recognition motifs and affinity for trypanocidal drugs. Mol. Pharmacol. 56:1162-1170.
12. Delespaux, V., and H. P. De Koning. 2007. Drugs and drug resistance in African trypanosomiasis. Drug Resist. Update 10:30-50.
13. Doerig, C., L. Meyer, and J. C. Mottram. 2002. Protein kinases as drug targets in parasitic protozoa. Trends Parasitol. 18:366-371.
14. Dorn, A., S. R. Vippagunta, H. Matile, C. Jaquet, J. L. Vennerstrom, and R. G. Ridley. 1998. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem. Pharmacol. 55:727-736.
15. Egan, T. J., D. C. Ross, and P. A. Adams. 1994. Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). FEBS Lett. 352:54-57.
16. El Kouni, M. H. 2003. Potential chemotherapeutic targets in the purine metabolism of parasites. Pharmacol. Ther. 99:283-309.
17. Gelb, M. H., and W. G. Hol. 2002. Parasitology. Drugs to combat tropical protozoan parasites. Science 297:343-344.
18. 6-substituted adenosine derivatives. Part I. Bioorg. Med. Chem. 10:769-777.
19. Harmse, L., R. van Zyl, N. Gray, P. Schultz, S. Leclerc, L. Meyer, C. Doerig, and I. Havlik. 2001. Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum. Biochem. Pharmacol. 62:341-348.
20. 6-substituted adenosine derivatives. Part 2. J. Comb. Chem. 4:302-314.
21. Legros, D., S. Evans, F. Maiso, J. C. Enyaru, and D. Mbulamberi. 1999. Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda. Trans. R. Soc. Trop. Med. Hyg. 93:439-442.
22. Lüscher, A., H. P. De Koning, and P. Mäser. 2007. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting. Curr. Pharm. Des. 13:555-567.
23. Matovu, E., M. L. Stewart, F. Geiser, R. Brun, P. Maser, L. J. Wallace, R. J. Burchmore, J. C. Enyaru, M. P. Barrett, R. Kaminsky, T. Seebeck, and H. P. De Koning. 2003. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. Eukaryot. Cell 2:1003-1008.
24. Mbwambo, Z. H., S. Apers, M. J. Moshi, M. C. Kapingu, S. Van Miert, M. Claeys, R. Brun, P. Cos, L. Pieters, and A. Vlietinck. 2004. Anthranoid compounds with antiprotozoal activity from Vismia orientalis. Planta Med. 70:706-710.
25. Reference deleted.
26. Mikus, J., and D. Steverding. 2000. A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar blue. Parasitol. Int. 48:265-269.
27. Natto, M. J., L. J. Wallace, D. Candlish, M. I. Al Salabi, S. E. Coutts, and H. P. De Koning. 2005. Trypanosoma brucei: expression of multiple purine transporters prevents the development of allopurinol resistance. Exp. Parasitol. 109:80-86.
28. Pepin, J., and F. Milord. 1994. The treatment of human African trypanosomiasis. Adv. Parasitol. 33:1-47.
29. Ridley, R. G., A. Dorn, S. R. Vippagunta, and J. L. Vennerstrom. 1997. Haematin (haem) polymerization and its inhibition by quinoline antimalarials. Ann. Trop. Med. Parasitol. 91:559-566.
30. Rodenko, B., R. J. Detz, V. A. Pinas, C. Lambertucci, R. Brun, M. J. Wanner, and G. J. Koomen. 2006. Solid phase synthesis and antiprotozoal evaluation of di- and trisubstituted 5′-carboxamidoadenosine analogues. Bioorg. Med. Chem. 14:1618-1629.
31. Rodenko, B., M. J. Wanner, and G. J. Koomen. 2002. Solid phase synthesis of C2,N-6-disubstituted adenosine analogues. J. Chem. Soc. Perkins Trans. 1:1247-1252.
32. Senge, M., and S. Hatscher. 2000. The malaria pigment haemozoin-a focal point of action for antimalarial drugs. Chembiochem 1:247-249.
33. Stead, A. M. W., P. G. Bray, I. G. Edwards, H. P. De Koning, B. C. Elford, P. A. Stocks, and S. A. Ward. 2001. Diamidine compounds: selective uptake and targeting in Plasmodium falciparum. Mol. Pharmacol. 59: 1298-1306.
34. Verlinde, C. L., V. Hannaert, C. Blonski, M. Willson, J. J. Perie, L. A. Fothergill-Gilmore, F. R. Opperdoes, M. H. Gelb, W. G. Hol, and P. A. Michels. 2001. Glycolysis as a target for the design of new anti-trypanosome drugs. Drug Resist. Update 4:50-65.
35. Wallace, L. J., D. Candlish, A. Hagos, K. L. Seley, and H. P. De Koning. 2004. Selective transport of a new class of purine antimetabolites by the protozoan parasite Trypanosoma brucei. Nucleosides Nucleotides Nucleic Acids 23:1441-1444.
36. Wallace, L. J. M., D. Candlish, and H. P. De Koning. 2002. Different substrate recognition motifs of human and trypanosome nucleobase transporters - selective uptake of purine antimetabolites. J. Biol. Chem. 277: 26149-26156.
37. World Health Organization. 2002. World health report 2002. http://www.who.int/whr/2002/en. World Health Organization, Geneva, Switzerland.